ISSN: 2157-7609
+44-77-2385-9429
Department of Pharmacology, University of Central Florida, Orlando, USA
Opinion Article
Evaluating the Sensitivity of HL-ICOs to Hepatotoxicants: Implications for In Vitro Toxicity Assessment
Author(s): John Simpson*
New developments in in vitro toxicity testing make an effort to
address the demand for trustworthy human-based safety
evaluation in medication development. The term "Intrahepatic
Cholangiocyte Organoids" (ICOs) refers to an in vitro disease
model for regenerative medicine that is developed from a donor.
Here, we investigated the expression and activity of genes
implicated in drug metabolism, a significant factor in druginduced
toxicity, and the exposure of Hepatocyte-like ICOs (HLICOs)
to well-known hepatotoxicants in order to examine the
potential of HL-ICOs in in vitro toxicity testing. In terms of
CYP3A4 expression, HL-ICOs' drug metabolism was equivalent
to that of Preventive Health and Health services (PHHs) and
HepaRGs, while other enzymes, such CYP2B6 and CYP2D6,
were expres.. View More»
DOI:
10.35248/2157-7609.23.14.289